Emmaus Life Sciences EMMA
OTC EMMA
$0.06 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Return on Capital Employed [ROCE] (2017 - 2022)

Updated

Emmaus Life Sciences (EMMA) recorded Return on Capital Employed [ROCE] of -393.97% in Q3 2022, down 391.78 percentage points from -2.19% a year earlier and down 37.35 percentage points from the prior quarter.

Analysis

Emmaus Life Sciences (EMMA) Return on Capital Employed [ROCE] (2017 - 2022) Analysis & Trends

For FY2021, Emmaus Life Sciences reported Return on Capital Employed [ROCE] of -29.13%, down 29.04 percentage points from FY2020.

  • Annual Return on Capital Employed [ROCE] has a four-year change of +374.76 percentage points (FY2017 to FY2021).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -0.09% in FY2020 (+12.97 pp), -13.06% in FY2019, -229.78% in FY2018 (+174.11 pp) and -403.89% in FY2017.
  • The Q3 2022 figure is the lowest quarterly Return on Capital Employed [ROCE] since Q2 2019.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined for five consecutive quarters, with an average year-over-year change of -98.07 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 2011.12 percentage points in Q2 2018, against a drop of 391.78 percentage points in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -356.62% (Q2 2022), -38.75% (Q1 2022) and -28.78% (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.52%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 17.92%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 6.28%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 16.76%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 16.66%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.86%
10 Emmaus Life Sciences 4.21 Mn -2.09 Mn 5.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -393.97%
Jun 30, 2022 -356.62%
Mar 31, 2022 -38.75%
Dec 31, 2021 -28.78%
Sep 30, 2021 -2.19%
Jun 30, 2021 -1.81%
Mar 31, 2021 -7.62%
Dec 31, 2020 -0.09%
Sep 30, 2020 0.89%
Jun 30, 2020 -10.82%
Mar 31, 2020 -6.23%
Dec 31, 2019 -17.39%
Sep 30, 2019 -27.13%
Jun 30, 2019 -1,002.94%
Mar 31, 2019 -96.10%
Sep 30, 2018 -275.58%
Jun 30, 2018 -331.77%
Mar 31, 2018 -380.52%
Dec 31, 2017 -235.75%
Sep 30, 2017 -336.70%
API Access

Emmaus Life Sciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EMMA&period=max&api_key=YOUR_API_KEY